tasmedLogo Tasmed
  Tas Med (India) Private Limited
 
 
HomeAbout UsProductsCareerImage GalleryContact
Messages What Our Goal Corporate Network Latest News Download
 
   
  Welcome to Tasmed.  
 
The company’s objective was to confirm to medicine meant for long term ailments at affordable price. Companys confining to Anti-Diabetic, Cardiac, Gasteroanthrology and Anti-Psychotic range. This ia testing

     
 
 
arrow Desk Of
plusSign Balwan Singh
  CMD
plusSign Harjinder Kumar
  Director
plusSign Babita Chaudhary
  Manager
 
 
downloads

 
TitleDescription
AMO 1-Decreases cardiovascular events without increase in coronary heart disease' 2-Offers lipid neutral profile and causes no disturbance in glucose homeostasis unlike other antihypertensives' 3-Effectively reduces the risk of cardiovascular events and delays the progression of renal disease in diabetic patients as per ADHT trial' a- Hypertension. b- Ischaemia. c- Coronary Artery Disease. d- Atherosclerosis. e- Oxidation.
ANTOX-FORTE 1-Helps minimizing effect of time on the body - Shows antioxidant effect and curbs free radicals 2-Also delays the progress of degenerative and ageing changes inside the body a- Hypertension b- Atherosclerosis c- Peptic Ulcer d- Parkinsonism e- Senile Dementi f- Diabetes Mellitus g- Colon Cancer
DIGON 1-Highly effective in HF caused by compromised contractile activity of myocardium,atrium fibrillation' 2-Equally effective in those with diastolic heart Failure 3-Also used for controlling number of heart contractions and supraventricular paroxysmal tachycardia 4-Displays beneficial effect on patients with: a-Pulmonary Hypertension b-Right Ventricular Failure
LOTAS 1-Offers the unique uricosuric effect unlike other ARBs 2-Also displays activity of active metabolites(10-40 times more potent)unlike other ARBs 3-No dosage titration in renal insufficiency unlike candesartan and telmisartan
AM-T 1-Decreases cardiovascular events without increase in coronary heart disease' 2-Offers lipid neutral profile and causes no disturbance in glucose homeostasis unlike other antihypertensives' 3-Effectively reduces the risk of cardiovascular events and delays the progression of renal disease in diabetic patients as per ADHT trial'a- Hypertension b- Ischaemia c- Coronary Artery Disease d- Atherosclerosis e- Oxidation
LOTAM 1-Helps lower BP toward therapeutic targets in patients with hypertension and diabetes as per ADHT study' 2-Reduces incidences of headache and peripheral oedema then CCB monotherapy 3-A valuable option for high risk patients as it offers the potential to a- Reduces adverse events b- Increases compliance c- Lower treatment costs d- Improvers BP goal-attainment rates 4-Indicated in monotherapy-resistant hypertension
LOTAS-HT 1-Offers the unique uricosuric effect unlike other ARBs 2-Also displays activity of active metabolites(10-40 times more potent)unlike other ARBs 3-No dosage titration in renal insufficiency unlike candesartan and telmisartan
 
arrow Achievements
plusSign New Product Posted On( 6/6/2009 7:57:47 PM )
  New range of products are added
 
 
arrow Latest NEWS
plusSign Checking2
  7/7/2009 10:41:14 AM
plusSign Checking
  6/11/2009 11:24:13 AM
 
Cardiology
 
Gastro
 
Diabetic
 
Neurology
 
Psychiatry
 
 
Copyright:2009 Tasmed Lab India Private Limited         Designed And Powered By InfowavesInfowaves